Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Avidity Biosciences (RNA) Other Non Operating Income: 2020-2025

Historic Other Non Operating Income for Avidity Biosciences (RNA) over the last 5 years, with Sep 2025 value amounting to -$380,000.

  • Avidity Biosciences' Other Non Operating Income fell 63.79% to -$380,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.3 million, marking a year-over-year decrease of 128.34%. This contributed to the annual value of -$248,000 for FY2024, which is 58.25% up from last year.
  • As of Q3 2025, Avidity Biosciences' Other Non Operating Income stood at -$380,000, which was up 41.63% from -$651,000 recorded in Q2 2025.
  • Avidity Biosciences' 5-year Other Non Operating Income high stood at $201,000 for Q4 2024, and its period low was -$651,000 during Q2 2025.
  • For the 3-year period, Avidity Biosciences' Other Non Operating Income averaged around -$209,818, with its median value being -$162,000 (2023).
  • Its Other Non Operating Income has fluctuated over the past 5 years, first crashed by 8,000.00% in 2023, then skyrocketed by 291.43% in 2024.
  • Avidity Biosciences' Other Non Operating Income (Quarterly) stood at -$46,000 in 2021, then skyrocketed by 60.87% to -$18,000 in 2022, then crashed by 483.33% to -$105,000 in 2023, then skyrocketed by 291.43% to $201,000 in 2024, then tumbled by 63.79% to -$380,000 in 2025.
  • Its Other Non Operating Income stands at -$380,000 for Q3 2025, versus -$651,000 for Q2 2025 and -$435,000 for Q1 2025.